Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IINN vs INVA vs AVAV vs PRGO vs TEVA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IINN
Inspira Technologies Oxy B.H.N. Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$10M
5Y Perf.-89.1%
INVA
Innoviva, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$1.69B
5Y Perf.+61.4%
AVAV
AeroVironment, Inc.

Aerospace & Defense

IndustrialsNASDAQ • US
Market Cap$8.40B
5Y Perf.+66.5%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.62B
5Y Perf.-75.6%
TEVA
Teva Pharmaceutical Industries Limited

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IL
Market Cap$41.60B
5Y Perf.+270.3%

IINN vs INVA vs AVAV vs PRGO vs TEVA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IINN logoIINN
INVA logoINVA
AVAV logoAVAV
PRGO logoPRGO
TEVA logoTEVA
IndustryMedical - DevicesBiotechnologyAerospace & DefenseDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$10M$1.69B$8.40B$1.62B$41.60B
Revenue (TTM)$289K$424M$1.61B$4.18B$17.35B
Net Income (TTM)$-13M$504M$-224M$-1.82B$1.56B
Gross Margin0.7%76.2%21.8%34.2%52.1%
Operating Margin45.1%14.8%-8.3%-4.1%13.2%
Forward P/E7.3x58.4x5.5x15.5x
Total Debt$3M$269M$64M$3.97B$17.38B
Cash & Equiv.$5M$551M$41M$532M$3.56B

IINN vs INVA vs AVAV vs PRGO vs TEVALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IINN
INVA
AVAV
PRGO
TEVA
StockJul 21May 26Return
Inspira Technologie… (IINN)10010.9-89.1%
Innoviva, Inc. (INVA)100161.4+61.4%
AeroVironment, Inc. (AVAV)100166.5+66.5%
Perrigo Company plc (PRGO)10024.4-75.6%
Teva Pharmaceutical… (TEVA)100370.3+270.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: IINN vs INVA vs AVAV vs PRGO vs TEVA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: INVA leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. TEVA also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IINN
Inspira Technologies Oxy B.H.N. Ltd.
The Healthcare Pick

IINN lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
INVA
Innoviva, Inc.
The Growth Play

INVA carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.

  • Rev growth 18.5%, EPS growth 8.2%, 3Y rev CAGR 8.7%
  • Lower volatility, beta 0.11, Low D/E 22.9%, current ratio 14.64x
  • Beta 0.11, current ratio 14.64x
  • 18.5% revenue growth vs IINN's -16.1%
Best for: growth exposure and sleep-well-at-night
AVAV
AeroVironment, Inc.
The Long-Run Compounder

AVAV is the clearest fit if your priority is long-term compounding.

  • 498.7% 10Y total return vs INVA's 95.6%
Best for: long-term compounding
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.21, yield 9.8%
  • Lower P/E (5.5x vs 15.5x)
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
TEVA
Teva Pharmaceutical Industries Limited
The Momentum Pick

TEVA ranks third and is worth considering specifically for momentum.

  • +97.7% vs PRGO's -52.0%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthINVA logoINVA18.5% revenue growth vs IINN's -16.1%
ValuePRGO logoPRGOLower P/E (5.5x vs 15.5x)
Quality / MarginsINVA logoINVA118.9% margin vs IINN's -43.7%
Stability / SafetyINVA logoINVABeta 0.11 vs AVAV's 1.55
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)TEVA logoTEVA+97.7% vs PRGO's -52.0%
Efficiency (ROA)INVA logoINVA32.4% ROA vs IINN's -275.8%, ROIC 14.2% vs 0.5%

IINN vs INVA vs AVAV vs PRGO vs TEVA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IINNInspira Technologies Oxy B.H.N. Ltd.

Segment breakdown not available.

INVAInnoviva, Inc.
FY 2025
Royalty
57.5%$236M
Product
41.8%$172M
License And Other Revenue
0.7%$3M
AVAVAeroVironment, Inc.
FY 2024
Product sales
81.7%$586M
Contract services
18.3%$131M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
TEVATeva Pharmaceutical Industries Limited
FY 2025
Product
84.6%$14.6B
Distribution Service
9.0%$1.6B
License
3.9%$678M
Product and Service, Other
2.5%$423M

IINN vs INVA vs AVAV vs PRGO vs TEVA — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLINVALAGGINGAVAV

Income & Cash Flow (Last 12 Months)

INVA leads this category, winning 4 of 6 comparable metrics.

TEVA is the larger business by revenue, generating $17.3B annually — 60027.7x IINN's $289,000. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to IINN's -43.7%. On growth, AVAV holds the edge at +143.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
RevenueTrailing 12 months$289,000$424M$1.6B$4.2B$17.3B
EBITDAEarnings before interest/tax$13M$86M$82M$58M$3.3B
Net IncomeAfter-tax profit-$13M$504M-$224M-$1.8B$1.6B
Free Cash FlowCash after capex$0$181M-$183M$108M$1.2B
Gross MarginGross profit ÷ Revenue+0.7%+76.2%+21.8%+34.2%+52.1%
Operating MarginEBIT ÷ Revenue+45.1%+14.8%-8.3%-4.1%+13.2%
Net MarginNet income ÷ Revenue-43.7%+118.9%-13.9%-43.5%+9.0%
FCF MarginFCF ÷ Revenue+42.6%-11.3%+2.6%+6.8%
Rev. Growth (YoY)Latest quarter vs prior year+10.6%+143.4%-7.2%+2.3%
EPS Growth (YoY)Latest quarter vs prior year+36.8%+4.0%-51.5%-56.4%+72.2%
INVA leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 6 comparable metrics.

At 6.9x trailing earnings, INVA trades at a 94% valuation discount to AVAV's 108.6x P/E. On an enterprise value basis, INVA's 6.9x EV/EBITDA is more attractive than IINN's 675.4x.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
Market CapShares × price$10M$1.7B$8.4B$1.6B$41.6B
Enterprise ValueMkt cap + debt − cash$8M$1.4B$8.4B$5.1B$55.4B
Trailing P/EPrice ÷ TTM EPS-709.83x6.94x108.57x-1.14x29.77x
Forward P/EPrice ÷ next-FY EPS est.7.31x58.45x5.53x15.50x
PEG RatioP/E ÷ EPS growth rate0.67x
EV / EBITDAEnterprise value multiple675.38x6.90x103.03x7.43x17.55x
Price / SalesMarket cap ÷ Revenue3.97x10.24x0.38x2.41x
Price / BookPrice ÷ Book value/share1.82x1.65x5.35x0.55x5.30x
Price / FCFMarket cap ÷ FCF8.63x11.17x36.24x
PRGO leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

INVA leads this category, winning 6 of 9 comparable metrics.

INVA delivers a 47.6% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $-4 for IINN. AVAV carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to TEVA's 2.20x. On the Piotroski fundamental quality scale (0–9), TEVA scores 8/9 vs IINN's 1/9, reflecting strong financial health.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
ROE (TTM)Return on equity-3.7%+47.6%-6.4%-50.7%+20.7%
ROA (TTM)Return on assets-2.8%+32.4%-5.0%-19.8%+3.9%
ROICReturn on invested capital+0.5%+14.2%+3.6%+3.7%+7.7%
ROCEReturn on capital employed+0.2%+12.4%+4.5%+4.3%+8.0%
Piotroski ScoreFundamental quality 0–915348
Debt / EquityFinancial leverage0.58x0.23x0.07x1.35x2.20x
Net DebtTotal debt minus cash-$3M-$282M$23M$3.4B$13.8B
Cash & Equiv.Liquid assets$5M$551M$41M$532M$3.6B
Total DebtShort + long-term debt$3M$269M$64M$4.0B$17.4B
Interest CoverageEBIT ÷ Interest expense63.45x-5.99x-7.20x2.51x
INVA leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TEVA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in TEVA five years ago would be worth $34,859 today (with dividends reinvested), compared to $897 for IINN. Over the past 12 months, TEVA leads with a +97.7% total return vs PRGO's -52.0%. The 3-year compound annual growth rate (CAGR) favors TEVA at 58.0% vs IINN's -33.1% — a key indicator of consistent wealth creation.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
YTD ReturnYear-to-date-53.7%+15.2%-34.3%-13.6%+15.4%
1-Year ReturnPast 12 months-21.1%+23.2%-0.1%-52.0%+97.7%
3-Year ReturnCumulative with dividends-70.0%+96.0%+63.2%-58.1%+294.4%
5-Year ReturnCumulative with dividends-91.0%+94.5%+63.2%-60.3%+248.6%
10-Year ReturnCumulative with dividends-91.0%+95.6%+498.7%-77.7%-28.8%
CAGR (3Y)Annualised 3-year return-33.1%+25.1%+17.7%-25.2%+58.0%
TEVA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — INVA and TEVA each lead in 1 of 2 comparable metrics.

INVA is the less volatile stock with a 0.11 beta — it tends to amplify market swings less than AVAV's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TEVA currently trades 95.7% from its 52-week high vs IINN's 25.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
Beta (5Y)Sensitivity to S&P 5001.41x0.11x1.55x1.21x1.08x
52-Week HighHighest price in past year$1.65$25.15$417.86$28.44$37.35
52-Week LowLowest price in past year$0.34$16.52$159.64$9.23$14.99
% of 52W HighCurrent price vs 52-week peak+25.8%+91.0%+40.3%+41.2%+95.7%
RSI (14)Momentum oscillator 0–10042.544.737.353.170.6
Avg Volume (50D)Average daily shares traded297K604K1.7M3.3M6.6M
Evenly matched — INVA and TEVA each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: INVA as "Buy", AVAV as "Buy", PRGO as "Hold", TEVA as "Buy". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs 10.0% for TEVA (target: $39). PRGO is the only dividend payer here at 9.82% yield — a key consideration for income-focused portfolios.

MetricIINN logoIINNInspira Technolog…INVA logoINVAInnoviva, Inc.AVAV logoAVAVAeroVironment, In…PRGO logoPRGOPerrigo Company p…TEVA logoTEVATeva Pharmaceutic…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$40.00$343.60$36.20$39.29
# AnalystsCovering analysts10283646
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises0101
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.3%0.0%0.0%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

INVA leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallInnoviva, Inc. (INVA)Leads 2 of 6 categories
Loading custom metrics...

IINN vs INVA vs AVAV vs PRGO vs TEVA: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IINN or INVA or AVAV or PRGO or TEVA a better buy right now?

For growth investors, Innoviva, Inc.

(INVA) is the stronger pick with 18. 5% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (7. 3x forward), making it the more compelling value choice. Analysts rate Innoviva, Inc. (INVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IINN or INVA or AVAV or PRGO or TEVA?

On trailing P/E, Innoviva, Inc.

(INVA) is the cheapest at 6. 9x versus AeroVironment, Inc. at 108. 6x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — IINN or INVA or AVAV or PRGO or TEVA?

Over the past 5 years, Teva Pharmaceutical Industries Limited (TEVA) delivered a total return of +248.

6%, compared to -91. 0% for Inspira Technologies Oxy B. H. N. Ltd. (IINN). Over 10 years, the gap is even starker: AVAV returned +498. 7% versus IINN's -91. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IINN or INVA or AVAV or PRGO or TEVA?

By beta (market sensitivity over 5 years), Innoviva, Inc.

(INVA) is the lower-risk stock at 0. 11β versus AeroVironment, Inc. 's 1. 55β — meaning AVAV is approximately 1260% more volatile than INVA relative to the S&P 500. On balance sheet safety, AeroVironment, Inc. (AVAV) carries a lower debt/equity ratio of 7% versus 2% for Teva Pharmaceutical Industries Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — IINN or INVA or AVAV or PRGO or TEVA?

By revenue growth (latest reported year), Innoviva, Inc.

(INVA) is pulling ahead at 18. 5% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, AVAV leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IINN or INVA or AVAV or PRGO or TEVA?

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus -43. 7% for Inspira Technologies Oxy B. H. N. Ltd. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IINN leads at 45. 1% versus 5. 0% for AVAV. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IINN or INVA or AVAV or PRGO or TEVA more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 58. 4x for AeroVironment, Inc. — 52. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.

08

Which pays a better dividend — IINN or INVA or AVAV or PRGO or TEVA?

In this comparison, PRGO (9.

8% yield) pays a dividend. IINN, INVA, AVAV, TEVA do not pay a meaningful dividend and should not be held primarily for income.

09

Is IINN or INVA or AVAV or PRGO or TEVA better for a retirement portfolio?

For long-horizon retirement investors, Innoviva, Inc.

(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 11)). Both have compounded well over 10 years (INVA: +95. 6%, IINN: -91. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IINN and INVA and AVAV and PRGO and TEVA?

These companies operate in different sectors (IINN (Healthcare) and INVA (Healthcare) and AVAV (Industrials) and PRGO (Healthcare) and TEVA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IINN is a small-cap quality compounder stock; INVA is a small-cap high-growth stock; AVAV is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock; TEVA is a mid-cap quality compounder stock. PRGO pays a dividend while IINN, INVA, AVAV, TEVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IINN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

INVA

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 71%
Run This Screen
Stocks Like

AVAV

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 71%
  • Gross Margin > 13%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

TEVA

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.